Servier Overview

  • Year Founded
  • 1954

Year Founded

  • Status
  • Private

  • Employees
  • 20,000

Employees

Servier General Information

Description

Operator of a pharmaceutical company intended to play a vital role in advancing medical science, improving patient outcomes, and addressing global healthcare challenges. The company researches, develops, and produces drugs for oncology, cardiology, metabolic, central nervous system, psychiatric, bone, muscle, and joint diseases, enabling doctors to prescribe generic drugs with minimal side effects for low-cost treatments.

Contact Information

Website
www.servier.com
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 50 Rue Carnot
  • 92284 Suresnes
  • France
+33 01
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 50 Rue Carnot
  • 92284 Suresnes
  • France
+33 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Servier Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a pharmaceutical company intended to play a vital role in advancing medical science, improving patient outco
Drug Discovery
Suresnes, France
20,000 As of 2026

Parma, Italy
 

Bresso, Italy
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Servier Competitors (37)

One of Servier’s 37 competitors is Chiesi Farmaceutici, a Private Debt Financed company based in Parma, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Chiesi Farmaceutici Private Debt Financed Parma, Italy
The Zambon Group Private Debt Financed Bresso, Italy
Merck & Co. Corporation Rahway, NJ
Pfizer Pakistan Corporation Karachi, Pakistan
Genentech Formerly VC-backed South San Francisco, CA
You’re viewing 5 of 37 competitors. Get the full list »

Servier Patents

Servier Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026229590-A1 Polycyclic derivatives, pharmaceutical compositions containing them, their combination with one or more anti-cancer agents, and their uses as pro-apoptotic agents Pending 30-Apr-2025
WO-2026220079-A1 Combination of ivosidenib, venetoclax and azacitidine for use in the treatment of aml or mds/aml Pending 18-Apr-2025
WO-2026219847-A1 Antibodies to il21r and compositions thereof Pending 14-Apr-2025
WO-2026082692-A1 Antibodies to cd40 and compositions thereof Pending 15-Oct-2024
WO-2026068485-A1 New process for the synthesis of 2',4'-bna ncnucleoside analogues Pending 25-Sep-2024 C07H1/00
To view Servier’s complete patent history, request access »

Servier Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Servier Investments & Acquisitions (21)

Servier’s most recent deal was a Merger/Acquisition with Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) for . The deal was made on 01-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Edgewise Therapeutics (Sevasemten and Muscular Dystrophy Business) 01-Jun-2026 Merger/Acquisition Laboratory Services (Healthcare)
Cytospire 05-May-2026 Early Stage VC Biotechnology
Day One Biopharmaceuticals 23-Apr-2026 Merger/Acquisition Drug Discovery
Kaerus Bioscience (KER-0193 Drug in London, United Kingdom) 08-Sep-2025 Corporate Asset Purchase Buildings and Property
Bio Nova Pharmaceuticals (BN104 Menin Inhibitor, Shanghai, China) 23-May-2025 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 21 investments and acquisitions. Get the full list »

Servier Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
Day One Biopharmaceuticals Brisbane, CA 2018
Symphogen Ballerup, Denmark 2000
Arts Et Technique Du Progres Orleans, France 1982
Servier Laboratories Pension Fund Bells hill, United Kingdom 1963
Egis Pharmaceuticals Budapest, Hungary 1913

Servier FAQs

  • When was Servier founded?

    Servier was founded in 1954.

  • Where is Servier headquartered?

    Servier is headquartered in Suresnes, France.

  • What is the size of Servier?

    Servier has 20,000 total employees.

  • What industry is Servier in?

    Servier’s primary industry is Drug Discovery.

  • Is Servier a private or public company?

    Servier is a Private company.

  • What is Servier’s current revenue?

    The current revenue for Servier is .

  • Who are Servier’s competitors?

    Chiesi Farmaceutici, The Zambon Group, Merck & Co., Pfizer Pakistan, and Genentech are some of the 37 competitors of Servier.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process